Dissemin
Language
العربيّة
Deutsch
English
Español
Suomi
Français
한국어
Македонски
Português
Português Brasileiro
Русский
Svenska
Türkçe
简体中文
繁體中文
Login
Dissemin
Matija Rijavec
Janzic et al., 2022
Links
ORCID
Tools
Export citation
×
Format
BibTeX
@misc{Janzic2022, author = {Janzic, U. and Bidovec-Stojkovic, U. and Mohorcic, K. and Mrak, L. and Dovnik, N. F. and Ivanovic, M. and Ravnik, M. and Caks, M. and Skof, E. and Debeljak, J. and Korosec, P. and Rijavec, M.}, month = {jan}, title = {Adequate Immunogenicity And Low Rate of Severe Adverse Events After SARS-CoV-2 mRNA-Based Vaccination In Patients With Solid Malignancies On Active Treatment Starts To Decline 3 Months After Complete Primary Course of Vaccination}, year = {2022} }
Export citation
Search in Google Scholar
Adequate Immunogenicity And Low Rate of Severe Adverse Events After SARS-CoV-2 mRNA-Based Vaccination In Patients With Solid Malignancies On Active Treatment Starts To Decline 3 Months After Complete Primary Course of Vaccination
Published in 2022 by
U. Janzic
,
U. Bidovec-Stojkovic
,
K. Mohorcic
,
L. Mrak
,
N. F. Dovnik
,
M. Ivanovic
,
M. Ravnik
,
M. Caks
,
E. Skof
,
J. Debeljak
,
P. Korosec
,
M. Rijavec
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
Full text:
Unavailable
Preprint
: policy unknown
Upload
Postprint
: policy unknown
Upload
Published version
: policy unknown
Upload